Parkinsonism-dystonia-2: Case-series study from Saudi Arabia
- PMID: 38389300
- PMCID: PMC11021621
- DOI: 10.1002/acn3.52020
Parkinsonism-dystonia-2: Case-series study from Saudi Arabia
Abstract
Parkinsonism-dystonia-2 PKDYS2 is an autosomal-recessive disorder, caused by pathogenic biallelic variants in SLC18A2 which encodes the vesicular monoamine transporter (VMAT2) protein. PKDYS2 is a treatable neurotransmitter disease, and the rate of diagnosis of this disorder has increased significantly with the advance of genomic technologies. Our report highlights a novel pathologic variant in one case and a novel finding on MRI Brain, consisting of a normal symmetrical signal intensity in the dorsal brainstem and pons, and it substantiates the significance of genetic testing in the evaluation of children with developmental delays, which influences clinical decisions to enhance patient outcomes.
© 2024 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Conflict of interest statement
None.
Figures

References
-
- Zhai H, Zheng Y, He Y, et al. A case report of infantile parkinsonism‐dystonia‐2 caused by homozygous mutation in the SLC18A2 gene. Int J Neurosci. 2023;133(5):574‐577. - PubMed
-
- Marecos C, Ng J, Kurian M. What is new for monoamine neurotransmitter disorders? J Inherit Metab Dis. 2014;37(4):619‐626. - PubMed
-
- Jacobsen JC, Wilson C, Cunningham V, et al. Brain dopamine‐serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder. J Inherit Metab Dis. 2016;39(2):305‐308. - PubMed
-
- Saida K, Maroofian R, Sengoku T, et al. Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: a study in 42 affected individuals. Genet Med. 2023;25(1):90‐102. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical